Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation
Abstract: Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow transplantation, respectively. These patients emphasize the need for long term follow-up of such patients. (Source: Leukemia Research)
